Q3 2025 InfuSystem Holdings Inc Earnings Call Transcript

Nov 4, 2025 / 02:00 PM GMT

Release Date Price: €6.85 (-18.93%)

Transcript 10-Q8-K

Key Points

Positve

InfuSystems Holdings Inc (INFU) reported a record net revenue of $36.2 million for Q3 2025, marking a 3.3% increase from the previous year.
The company achieved a record gross profit of $20.8 million, with a significant improvement in gross margin percentage to over 57%.
Oncology net revenue reached an all-time high, driven by a new contract with a large hospital system, enhancing market share.
The acquisition of Apollo has streamlined billing processes, reducing processing costs and improving efficiency in wound care claims.
InfuSystems Holdings Inc (INFU) secured a multi-year contract extension with a major national insurance payer, including a price increase and enhanced service coverage.

Negative

Revenue from the biomedical services segment is expected to decrease by $6 to $7 million annually due to a contract amendment with its largest customer.
Device Solutions net revenue decreased by 2.9%, primarily due to lower revenue volume in biomedical services.
The company incurred $773,000 in expenses related to an ERP software upgrade, contributing to a 7.8% increase in selling, general, and administrative expenses.
The transition to a new biomedical services contract will require resizing and relocating field-based technicians, incurring additional costs.
Despite revenue growth, the company faces a significant headwind in the device solutions segment due to changes in a major contract.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

INFU.A - InfuSystem Holdings Inc
Q3 2025 InfuSystem Holdings Inc Earnings Call
Nov 04, 2025 / 02:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good day and welcome to the MP System 3rd quarter 2025 earnings conference call. All participants will be in listen-only mode. Should you need assistance, please signal a conference specialist by pressing the key, followed by zero.

After today's presentation, there will be an opportunity to ask questions. To ask a question, you may press star then one on a touchtone phone.

To withdraw your question, please press 2. Please note this event is being recorded.

I would now like to turn the conference over to Joe Dorme of Wham Partners. Please go ahead.

--------------------------------------------------------------------------------
Unidentified_2 [2]
-------------------------------------

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.